全文获取类型
收费全文 | 1317篇 |
免费 | 70篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 41篇 |
妇产科学 | 28篇 |
基础医学 | 166篇 |
口腔科学 | 50篇 |
临床医学 | 78篇 |
内科学 | 355篇 |
皮肤病学 | 24篇 |
神经病学 | 136篇 |
特种医学 | 26篇 |
外科学 | 131篇 |
综合类 | 4篇 |
预防医学 | 106篇 |
眼科学 | 12篇 |
药学 | 71篇 |
中国医学 | 5篇 |
肿瘤学 | 157篇 |
出版年
2024年 | 4篇 |
2023年 | 15篇 |
2022年 | 24篇 |
2021年 | 52篇 |
2020年 | 28篇 |
2019年 | 39篇 |
2018年 | 48篇 |
2017年 | 31篇 |
2016年 | 41篇 |
2015年 | 39篇 |
2014年 | 45篇 |
2013年 | 63篇 |
2012年 | 103篇 |
2011年 | 93篇 |
2010年 | 55篇 |
2009年 | 52篇 |
2008年 | 85篇 |
2007年 | 96篇 |
2006年 | 87篇 |
2005年 | 68篇 |
2004年 | 72篇 |
2003年 | 62篇 |
2002年 | 54篇 |
2001年 | 12篇 |
2000年 | 11篇 |
1999年 | 6篇 |
1998年 | 10篇 |
1997年 | 4篇 |
1996年 | 7篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 8篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1988年 | 5篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1980年 | 2篇 |
1979年 | 7篇 |
1978年 | 2篇 |
1976年 | 4篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 3篇 |
1967年 | 2篇 |
1966年 | 3篇 |
排序方式: 共有1394条查询结果,搜索用时 312 毫秒
1.
2.
3.
4.
Megakaryocytic Progenitors Can Be Generated Ex Vivo and Safely Administered to Autologous Peripheral Blood Progenitor Cell Transplant Recipients 总被引:9,自引:1,他引:8
5.
Giovanni Corrao Antonella Zambon Lorenza Bertù Anna Mauri Valentina Paleari Camillo Rossi Mauro Venegoni 《Drug safety》2006,29(10):889-896
OBJECTIVE: To investigate the association between the use of fluoroquinolone agents and the risk of tendinitis in a large population-based case-control study. METHODS: The study was performed by linking automated health databases from the Region of Lombardia, Italy. Cases were patients aged > or =18 years who had a hospital discharge diagnosis of non-traumatic tendinitis in 2002-3. For each case, up to five controls were randomly selected among those eligible for inclusion in the study. A conditional logistic regression model was used to estimate the odds ratio of tendinitis associated with the current, recent and past use of fluoroquinolones. Odds ratios were adjusted for exposure to other antibacterials and other drugs. RESULTS: 22,194 cases and 104,906 controls met the inclusion criteria. Current use of fluoroquinolones significantly increased the risk of tendon disorders as a whole (odds ratio [OR] = 1.7; 95% CI 1.4, 2.0), tendon rupture (OR = 1.3; 95% CI 1.0, 1.8) and rupture of the Achilles' tendon (OR = 4.1; 95% CI 1.8, 9.6). Concomitant use of corticosteroids and fluoroquinolones increased the risk of both tendon rupture (OR = 3.1; 95% CI 1.5, 6.3) and rupture of the Achilles' tendon (OR = 43.2; 95% CI 5.5, 341.1). DISCUSSION: Evidence that exposure to fluoroquinolones is associated with the sudden occurrence of tendinitis is supported by this large population-based study. We can estimate that a single case of rupture of the Achilles' tendon would occur for every 5958 persons treated with fluoroquinolones (95% CI 2148, 23,085). The corresponding number needed to harm is 979 (95% CI 122, 9172) for patients who concomitantly use corticosteroids and 1638 (95% CI 351, 8843) for those aged >60 years. CONCLUSION: Clinicians should be aware of this adverse effect, and the increased risk for fluoroquinolone-associated tendinitis in elderly patients with corticosteroid use must be considered when these agents are prescribed. 相似文献
6.
Pedro Magno José Loureiro Alexandre Marques Pedro Farto E Abreu Machado Candido Paulo Leal Victor M Gil 《Revista portuguesa de cardiologia》2007,26(10):1033-1042
Ischemic stroke occurs in 0.2-0.4% of patients undergoing left heart catheterization, and is responsible for 5-10% of the mortality associated with the procedure. The main predisposing factors for this complication are female gender, complex atherosclerotic plaques in the ascending aorta, and peripheral arterial disease. The possibility of timely intervention with reperfusion therapy supports close clinical monitoring during the immediate post-catheterization period. The cardiologist should be familiar with the various types of stroke reperfusion therapy and its indications according to the time interval between catheterization and the stroke. The decision should be discussed with neurology and neuroradiology. 相似文献
7.
8.
9.
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 总被引:2,自引:0,他引:2
Peros E Geroldi D D'Angelo A Falcone C Montagna L Carabela M Emanuele E 《International journal of molecular medicine》2004,13(2):243-247
Lipoprotein(a) [Lp(a)] is an atherogenic and prothrombotic molecule formed by the covalent binding of the highly polymorphic apolipoprotein(a) [apo(a)] to apoprotein B-100 of LDL. High Lp(a) concentrations are a recognized genetic risk factor for coronary heart disease (CHD) and have been shown to be related with a familial clustering of ischemic cardiac events. Nevertheless, the association between apolipoprotein(a) isoforms and a positive familial history of CHD has received far less attention. In this report, we explored the distribution of apo(a) phenotypes in 127 CHD subjects with a family history of coronary events and in 92 CHD patients without such a history. Twenty-two apo(a) isoforms were detected by a high-resolution immunoblotting method. In univariate analysis, the percentage of subjects with at least one small sized apo(a) isoform was significantly higher in CHD patients with a positive family history than in those without (P<0.01). Multivariate analysis showed that apo(a) isoforms of low molecular weight were the best predictors of familial aggregation of cardiac ischemia. We conclude that apo(a) size polymorphism is strongly associated with a familial history of CHD and is more efficient than Lp(a) plasma concentrations in predicting the familial clustering of coronary disease. When detected by high-resolution techniques, apo(a) phenotypes are objective laboratory markers that can substitute for a knowledge of a positive family history of CHD and should be used, together with Lp(a) levels, to better assess the familial predisposition to coronary events. 相似文献
10.